A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Early-Stage Parkinson's Disease (PADOVA): Rationale, Design, and Baseline Data
PARKINSONISM & RELATED DISORDERS（2025）
关键词
Alpha-synuclein,Clinical trial,Monoamine oxidase,Levodopa,Monoclonal antibodies,Parkinson's disease
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要